-

MERGER ALERT: Kaskela Law LLC Announces Stockholder Investigation of Pactiv Evergreen Inc. (PTVE) and Encourages Investors to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating Pactiv Evergreen Inc. (NASDAQ: PTVE) (“Pactiv”) on behalf of the company’s shareholders.

Pactiv shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or online at https://kaskelalaw.com/case/pactiv-evergreen/, to receive additional information about this investigation and their legal rights and options.

On December 9, 2024, Pactiv announced that it had agreed to be acquired by Novolex at a price of $18.00 per share in cash. Following the closing of the proposed transaction, Pactiv’s stockholders will be cashed out of their investment position and the company’s shares will no longer be publicly traded.

Kaskela Law LLC’s investigation seeks to determine whether $18.00 per share represents adequate consideration for Pactiv’s shares, and if the proposed transaction as currently structured is fair to Pactiv’s stockholders.

Pactiv shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750 to receive additional information about this investigation and their legal rights and options. Alternatively, investors may submit their information to the firm by clicking on the following link (or if necessary, by copying and pasting the link into your browser):

https://kaskelalaw.com/case/pactiv-evergreen/

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.

This notice may constitute attorney advertising in certain jurisdictions.

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

Kaskela Law LLC

NASDAQ:PTVE

Release Versions

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

More News From Kaskela Law LLC

Kaskela Law Firm Reports Ongoing Shareholder Investigation of Reservoir Media, Inc. and Encourages Investors to Contact the Firm – RSVR

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law is investigating Reservoir Media, Inc. (NASDAQ: RSVR) on behalf of the company's shareholders....

Kaskela Law Firm Reports Ongoing Shareholder Investigation of Priority Technology Holdings, Inc. and Encourages Investors to Contact the Firm – PRTH

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC is conducting a stockholder investigation into Priority Technology Holdings, Inc. (NASDAQ: PRTH) (“Priority Technology”). The investigation seeks to determine whether Priority Technology and/or the company’s representatives violated the securities laws or breached their fiduciary duties in connection with recent corporate actions. Priority Technology shareholders should contact Kaskela Law (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 2...

SELECT MEDICAL STOCK ALERT: Does $16.50 Per Share Represent a Fair Shareholder Buyout Price? Kaskela Law Firm Announces Investigation into Fairness of Buyout Offer and Encourages Investors to Contact the Firm – SEM

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC is investigating the recently announced buyout of Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) shareholders to determine whether the $16.50 per share buyout offer is fair to the company’s investors or if it undervalues the company’s shares. Click here for additional information: https://kaskelalaw.com/case/select-medical/ On March 2, 2026, Select Medical announced that it had agreed to be acquired by an investment consortium at a pr...
Back to Newsroom